PRMT5 inhibitors and uses thereof
US9365519B2 · kind B2 · utility
34Cited by
29References
39Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 11, 2015 |
| Grant date | Jun 14, 2016 |
| Priority date | — |
| Expiry date | Feb 11, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are compounds of Formula (I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5-mediated disorders are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.